Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study - Test2 - elhamkhani - TriplyDB

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

http://www.wikidata.org/entity/Q24654287

about

Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Early detection of diabetic kidney disease: Present limitations and future perspectives Chronic kidney disease screening methods and its implication for Malaysia: an in depth review Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)New susceptibility loci associated with kidney disease in type 1 diabetes.Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data.Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians.Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study.Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.Association of cystatin C with adverse outcomes.Development and validation of GFR-estimating equations using diabetes, transplant and weight The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.Proteomic discovery of diabetic nephropathy biomarkers.Cystatin C identifies chronic kidney disease patients at higher risk for complications.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study.Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.Risks of rapid decline renal function in patients with type 2 diabetes Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes.Kidney function and clinical recommendations of drug dose adjustment in geriatric patients.Effect of enhanced external counterpulsation treatment on renal function in cardiac patients.Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations.Racial and ethnic differences in kidney function decline among persons without chronic kidney disease Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.

P2860

Q21558546-05C89DBD-9526-4397-BA81-3079BB594973 Q24635177-F4B55BF1-6F28-4811-985E-DE4EC5EC9296 Q24646339-85186919-AD16-4251-919E-40D5C2D3803D Q26741494-EB3FEB8C-B3DF-4893-A789-6ED3387D2FE8 Q26822369-515097F2-3889-402D-A728-9F94A6A12FBC Q28387350-33A90A74-7BB9-4C3B-880D-7175290DB28B Q29417066-0E8EB64D-8DA1-4CB9-93A2-F3A806E97DC5 Q30423005-C7E7913E-BD59-4DEE-904D-EAA83BE09D09 Q31067194-88361123-9724-4C9C-9FD5-B6DA91100E0A Q31071745-6F5858F6-A22C-4678-8307-ADF32DC242B4 Q31112191-FDC5585E-E809-4260-A623-1B8854D435A5 Q33357921-661658F9-BC12-4BB4-BDD0-FF6653CECA4C Q33562005-80BC5ECA-3CC9-4ADE-9092-A84CFCED85D0 Q33583018-6236F4BF-FC2D-40F3-8E45-F55568752B4A Q33591588-453B0B11-B998-4621-933F-18795C0F9D32 Q33608612-16A012DB-9A15-411F-856D-EF401962835A Q33617174-FE5355A3-D09E-4860-8ED5-7CE8EF4DD91A Q33646576-0DEED426-7BD4-40BA-888C-9C0F9767690F Q33819382-9E8D6E7A-B1FE-4284-A488-C3756A9EDCB4 Q33873169-6E9BD22C-BFB1-4AC5-B49C-85750B1E8B7A Q33905277-B021F191-765D-4D1E-BE00-CB41721A9350 Q33932292-037E08A1-3488-477C-9DC5-9ABA4DD1CF83 Q34021345-5ADC4D8C-00E5-41DE-B43A-D3872ABA665D Q34092120-BA76701F-B93E-4AB3-B0FE-11B6968A9413 Q34150807-E5344C7C-6172-40C5-8784-221EAB5F48A8 Q34292912-7988834E-B4DA-4F12-92EE-CC85490AACFD Q34330236-C9766363-0BEE-4D43-A63B-18F391F7B796 Q34457290-07B7858F-1CEC-482C-AFF4-57074AD19D64 Q34519960-3F44FA61-7AEE-4F1B-BF81-C738128FD5BB Q34538110-A096B055-4EE4-4461-B40E-244725C47FE8 Q34699197-E6B29709-5136-4E7D-9980-867FF2DA2ACB Q34751900-96CDBF4C-7ACE-479B-BB7D-D2D46D5D7339 Q34983087-273F5FCC-D4EE-4928-B8AE-773C67E2231D Q34983153-971EE35D-0533-4B27-8A69-30A04C9EF1A3 Q35020305-CE0BC416-A408-40EB-9096-D6FA3011EBDD Q35025494-2D4861DA-EC4F-48CD-8AB8-BE2320EEC543 Q35108889-31FF7A76-C92A-403C-8733-3D8E512D98B7 Q35123425-1882D83D-990C-4727-8ED6-4848C80F452A Q35133148-8DAF45A3-07C6-4E49-BF6D-A698FF935A11 Q35189566-ABFB10D6-9155-42BA-8F9D-58EACEF860BC

P2860

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

http://www.wikidata.org/entity/Q24654287

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Detection of renal function de ...... ts of a 4-year follow-up study

@ast

Detection of renal function de ...... ts of a 4-year follow-up study

@en

Detection of renal function de ...... ts of a 4-year follow-up study

@nl

type

label

Detection of renal function de ...... ts of a 4-year follow-up study

@ast

Detection of renal function de ...... ts of a 4-year follow-up study

@en

Detection of renal function de ...... ts of a 4-year follow-up study

@nl

prefLabel

Detection of renal function de ...... ts of a 4-year follow-up study

@ast

Detection of renal function de ...... ts of a 4-year follow-up study

@en

Detection of renal function de ...... ts of a 4-year follow-up study

@nl

P1433

Q24654287-F95AC23B-1027-4A52-88A0-5C7F735D6830

P1476

Q24654287-67058873-9D67-4D23-9FDD-72808F16C4EF

P2093

Q24654287-0B63B867-F478-474C-9D19-B96C4E3E9E77

Q24654287-5F400280-0665-458C-A01F-E65A77FBD5BD

Q24654287-7E3B7B2C-C068-4251-99E1-B03DC66C938A

Q24654287-823683C3-1D03-4EB1-A557-F122A4A63DA0

Q24654287-8C506282-39C0-4F4C-BCDA-E54CC7C95254

Q24654287-8D73010B-87A5-447B-BC0E-CF976DF54733

Q24654287-DA5F8978-5CB9-4126-B244-C51AE42358AB

P2860

Q24654287-015954A9-E0DF-4B55-B010-B6D107C140B3

Q24654287-026D2A80-590F-4094-97E6-E3A0C51934A1

Q24654287-03956E6E-5EBD-4538-A3E9-FC55E4DC6056

Q24654287-138EE9D6-1414-4CFB-B51E-833856F323DE

Q24654287-18580E7F-A6B6-4384-8C13-37312DA77269

Q24654287-1CAD3261-B1A8-4AAC-8DE0-FE082ECC0A85

Q24654287-1EE62F8F-896C-4406-9644-9554C63C79A9

Q24654287-20490D96-F74A-4F53-AD04-5171AEECB685

Q24654287-3E95C691-49CD-401E-B47B-88067B945A04

Q24654287-4615B120-8645-4CB3-A454-F64A7F0C53C7

P304

Q24654287-A75BE079-E2A8-416E-93E3-547DA151BAB7

P31

Q24654287-F85503CB-A0EF-4925-97C8-49DBB4AA336B

P3181

Q24654287-AE2834A3-5AA5-4E48-8DC5-CCD092EA916C

P356

Q24654287-1605BBB3-26B4-412F-BB06-FED03BB8A218

P407

Q24654287-E8E9423F-1456-438D-876A-DD2165343CD4

P433

Q24654287-714E6CED-9A2E-44A7-9659-D8C5EF136363

P478

Q24654287-2F07AD8D-EC9D-466C-B55E-7DBF050869F1

P577

Q24654287-98E01098-90F5-4BD8-8873-5F14FCC7A493

P698

Q24654287-F4FA5D42-D711-4450-B61E-F71B89E7C038

P921

Q24654287-273C668A-B25D-4137-AB22-09688B7D3CC4

P932

Q24654287-815EAB99-EF74-40A0-9F84-40AF26A602D4

P3181

P356

P1433

Journal of the American Society of Nephrology

P1476

Detection of renal function de ...... ts of a 4-year follow-up study

@en

P2093

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Betsy E P Ostrander

http://www.w3.org/2001/XMLSchema#string

Bruce A Perkins

http://www.w3.org/2001/XMLSchema#string

Bryan D Myers

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Kristina L Blouch

http://www.w3.org/2001/XMLSchema#string

Robert G Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

How to assess glomerular function and damage in humans.

Serum cystatin C as an endogenous marker of the renal function--a review.

Developments in the assessment of glomerular filtration rate.

Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset

Serum cystatin C as a marker of glomerular filtration rate.

P304

1404-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4723582

http://www.w3.org/2001/XMLSchema#string

P356

10.1681/ASN.2004100854

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15788478

http://www.w3.org/2001/XMLSchema#string

P921

P932

2429917

http://www.w3.org/2001/XMLSchema#string